Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...

European Union leaders are meeting in Brussels to address key global and regional issues. They will discuss Thursday tougher ...

Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...

The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with ...

The European Court of Justice's advocate general on Thursday proposed that Google's appeal against a record 4.1-billion-euro ...

European regulators poised to launch antitrust probe into food group’s takeover of Pringles and Pop-Tarts maker ...

European health officials are warning that the popular weight-loss drugs Ozempic and Wegovy can cause a potentially dangerous eye condition as a side effect. The European Medicines Agency’s safety ...

The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side effect of Novo Nordisk's popular treatments Ozempic and Wegovy, it said on ...

In the first four months of 2025 alone, Portuguese consumers spent nearly €20 million euros on GLP-1-based injectables like tirzepatide (Mounjaro) and semaglutide (Wegovy)—both of ... audits in ...